Frailty modeling of the bimodal age-incidence of Hodgkin lymphoma in the Nordic countries

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1350-7. doi: 10.1158/1055-9965.EPI-10-1014. Epub 2011 May 10.

Abstract

Background: The bimodality of the age-incidence curve of Hodgkin lymphoma (HL) has been ascribed to the existence of subgroups with distinct etiologies. Frailty models can be usefully applied to age-incidence curves of cancer to aid the understanding of biological phenomena in these instances. The models imply that for a given disease, a minority of individuals are at high risk, compared with the low-risk majority.

Methods: Frailty modeling is applied to interpret HL incidence on the basis of population-based cancer registry data from the five Nordic countries for the period 1993 to 2007. There were a total of 8,045 incident cases and 362,843,875 person-years at risk in the study period.

Results: A bimodal frailty analysis provides a reasonable fit to the age-incidence curves, employing 2 prototype models, which differ by having the sex covariate included in the frailty component (model 1) or in the baseline Weibull hazard (model 2). Model 2 seemed to fit better with our current understanding of HL than model 1 for the male-to-female ratio, number of rate-limiting steps in the carcinogenic process, and proportion of susceptibles; whereas model 1 performed better related to the heterogeneity in HL among elderly males.

Conclusion: The present analysis shows that HL age-incidence data are consistent with a bimodal frailty model, indicating that heterogeneity in cancer susceptibility may give rise to bimodality at the population level, although the individual risk remains simple and monotonically increasing by age.

Impact: Frailty modeling adds to the existing body of knowledge on the heterogeneity in risk of acquiring HL.

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Aged
  • Aged, 80 and over
  • Child
  • Child, Preschool
  • Denmark / epidemiology
  • Female
  • Finland / epidemiology
  • Hodgkin Disease / epidemiology*
  • Humans
  • Iceland / epidemiology
  • Incidence
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Norway / epidemiology
  • Proportional Hazards Models
  • Registries
  • Sweden / epidemiology
  • Young Adult